Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Austin

Showing results (541-550 of 786) with videos related to

Pageof 79
Sort By:
Analytical Chemistry|November 2, 2016
Heparin Isomeric Oligosaccharide Separation Using Volatile Salt Strong Anion Exchange ChromatographyRebecca L Miller, Scott E Guimond, Maitreyi Shivkumar, et al.
The American Journal of Cardiology|August 18, 2000
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American menM A Austin, B L Rodriguez, B McKnight, et al.
Nature|March 18, 1993
Germ-line transmission and expression of a human-derived yeast artificial chromosomeA Jakobovits, A L Moore, L L Green, et al.
Circulation|June 1, 2000
Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoterP J Talmud, K L Edwards, C M Turner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-lifeJames A Austin, Gareth S A Wright, Seiji Watanabe, et al.
Blood|March 11, 2004
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemiaElaine Willmore, Sarah de Caux, Nicola J Sunter, et al.
The Journal of Biological Chemistry|June 30, 1995
Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II betaC A Austin, K L Marsh, R A Wasserman, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|October 29, 2009
Demographic characteristics, care, and outcomes for children with oral clefts in three states using participants from the National Birth Defects Prevention StudyPeter Damiano, Margaret Tyler, Paul A Romitti, et al.
Biochimica Et Biophysica Acta|June 7, 1996
Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisationD W Zandvliet, A M Hanby, C A Austin, et al.
Toxicology Letters|July 23, 2013
Alpha, beta-unsaturated lactones 2-furanone and 2-pyrone induce cellular DNA damage, formation of topoisomerase I- and II-DNA complexes and cancer cell deathJosé Manuel Calderón-Montaño, Estefanía Burgos-Morón, Manuel Luis Orta, et al.
Pageof 79

Showing results (541-550 of 786) with videos related to

Sort By:
Pageof 79
Analytical Chemistry|November 2, 2016
Heparin Isomeric Oligosaccharide Separation Using Volatile Salt Strong Anion Exchange ChromatographyRebecca L Miller, Scott E Guimond, Maitreyi Shivkumar, et al.
The American Journal of Cardiology|August 18, 2000
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American menM A Austin, B L Rodriguez, B McKnight, et al.
Nature|March 18, 1993
Germ-line transmission and expression of a human-derived yeast artificial chromosomeA Jakobovits, A L Moore, L L Green, et al.
Circulation|June 1, 2000
Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoterP J Talmud, K L Edwards, C M Turner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-lifeJames A Austin, Gareth S A Wright, Seiji Watanabe, et al.
Blood|March 11, 2004
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemiaElaine Willmore, Sarah de Caux, Nicola J Sunter, et al.
The Journal of Biological Chemistry|June 30, 1995
Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II betaC A Austin, K L Marsh, R A Wasserman, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|October 29, 2009
Demographic characteristics, care, and outcomes for children with oral clefts in three states using participants from the National Birth Defects Prevention StudyPeter Damiano, Margaret Tyler, Paul A Romitti, et al.
Biochimica Et Biophysica Acta|June 7, 1996
Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisationD W Zandvliet, A M Hanby, C A Austin, et al.
Toxicology Letters|July 23, 2013
Alpha, beta-unsaturated lactones 2-furanone and 2-pyrone induce cellular DNA damage, formation of topoisomerase I- and II-DNA complexes and cancer cell deathJosé Manuel Calderón-Montaño, Estefanía Burgos-Morón, Manuel Luis Orta, et al.
Pageof 79